Skip to main content
. 2017 Mar 29;17(5):361–373. doi: 10.1007/s40256-017-0221-8

Table 2.

Acronyms and full names of trials mentioned in this article

Short name Full name
AF-CHF Atrial Fibrillation and Congestive Heart Failure
AFFIRM The Atrial Fibrillation Follow-up Investigation of Rhythm Management
BEST Beta-Blocker Evaluation in Survival Trial
BHAT Beta Blocker Heart Attack Trial
BIP Bezafibrate Intervention Study
CAPRICORN Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction
CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance
CIBIS-II Cardiac Insufficiency Bisoprolol Study
COMET Carvedilol Or Metoprolol European Trial
COMMIT Clopidogrel and Metoprolol in Myocardial Infarction Trial
COPERNICUS Carvedilol Prospective Randomized Cumulative Survival
ISIS-1 First International Study of Infarct Survival
J-DHF Japanese Diastolic Heart Failure Study
MERIT-HF Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure
MIAMI Metoprolol in acute myocardial infarction
MOCHA Multicenter Oral Carvedilol Heart Failure Assessment
MUSTT Multicenter Unsustained Tachycardia Trial
PRECISE Percutaneous Robotically Enhanced Coronary Intervention
SENIORS Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure
UKPDS UK Prospective Diabetes Study
β-PRESERVE Rationale and design of the β-blocker in heart failure with normal left ventricular ejection fraction